NCT06784557View on ClinicalTrials.gov

Effect of Ezetimibe on Gut Microbiota

PHASE4RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

October 1, 2025

Conditions
Atherosclerotic Cardiovascular Disease With Dyslipidemia
Interventions
DRUG

Atorvastatin 40mg

High intensity HMG-CoA reductase inhibitor

DRUG

Atorvastatin 20mg+Ezetimibe 10mg

Moderate intensity HMG-CoA reductase inhibitor plus NPC1L1 antagonist

Trial Locations (1)

Unknown

RECRUITING

Severance hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER